BOEHRINGER MANNHEIM RETEPLASE LABEL SHOULD AVOID COMPARISONS TO ACTIVASE, FDA ADVISORY CMTE. SAYS; BLEEDING COMPLICATIONS SIMILAR TO STREPTOKINASE
Executive Summary
Boehringer Mannheim reteplase labeling should not contain efficacy comparisons to Genentech's Activase (alteplase), FDA's Cardiovascular & Renal Drugs Advisory Committee recommended May 3.